logo-loader
viewBenchmark Holdings PLC

Benchmark Holdings focused on making core business 'commercially profitable'

Benchmark Holdings PLC's (LON:BMK) CEO Trond Williksen and CFO Septima Maguire says they're pleased with what's been achieved with its restructuring programme following the sales of FishVet and Improve International.

Williksen says it demonstrates their ability to execute and deliver on its promises and are 'walking the talk' which will be very important for them going forward.

Quick facts: Benchmark Holdings PLC

Price: 41 GBX

AIM:BMK
Market: AIM
Market Cap: £273.73 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Benchmark Holdings PLC named herein, including the promotion by the Company of Benchmark Holdings PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Benchmark Holdings' Peter George says sale of its vaccine facility is a...

Benchmark Holdings PLC's (LON:BMK) chairman Peter George speaks to Proactive London's Andrew Scott soon after agreeing to sell its vaccine manufacturing assets at its facility in Braintree, UK to Cell and Gene Therapy Catapult. George says he's pleased that Benchmark has been able to be part of...

2 weeks, 3 days ago

2 min read